Sylvain Charlebois, a food researcher and professor at Dalhousie University in Halifax, said the industry has been particularly vulnerable to cyberattacks in recent weeks.
The treatment is approved for patients who have a moderate to high risk of recurrence, following nephrectomy or nephrectomy accompanied by surgical resection of metastatic lesions.
